Key result
Delayed-enhancement cardiac MRI provides a noninvasive approach to tissue characterization that can accurately differentiate cardiomyopathies and identify pathologic tissues amenable to therapy.
Delayed-enhancement cardiac MRI is a valuable noninvasive tool for defining cardiac anatomy, identifying pathologic tissues, differentiating cardiomyopathies, and providing prognostic information.
Supports noninvasive cardiomyopathy evaluation now; leaves open prospective trials to confirm therapeutic impact.
Cardiomyopathies are a diverse group of disorders with etiologies ranging from ischemic to infiltrative. Clinical differentiation may be complex, but diagnosis is essential as complications include congestive heart failure and sudden death. Recent developments in cardiac MRI, particularly the implementation of delayed-enhancement imaging has introduced a novel approach to noninvasive tissue characterization that can more accurately differentiate the spectrum of cardiomyopathies. This article summarizes the comprehensive diagnostic abilities of cardiac MRI in defining cardiac anatomy and physiology and, more importantly, identifying pathologic tissues and differentiating those with substrates amenable to therapy. The value of delayed-enhancement imaging in prognostics will also be presented.
No takes yet. Share an insight, caveat, or question.
Boonyasiranant et al. (2010) conducted a review in Cardiomyopathies. Delayed-enhancement cardiac MRI was evaluated. Delayed-enhancement cardiac MRI provides a noninvasive approach to tissue characterization that can accurately differentiate cardiomyopathies and identify pathologic tissues amenable to therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: